text stringlengths 1 17.8k |
|---|
If no hearing is held, the DC shall issue its recommendation within fourteen (14) days of the communication to the parties that no hearing will be held. |
Where t he DC considers that a Laboratory ’s accreditation should be suspended or subject to an Analytical Testing Restriction , it shall recommend to the Chair of the WADA Executive Committee a period of Suspension or Analytical Testing Restriction that is proportionate to the seriousness of the noncompliance(s) with the ISL and/or Technical Document (s) and/or Technical Letters and the need to ensure accurate and reliable Analytical Testing of Samples . |
The DC may recommend to the Chair of the WADA Executive Committee that a Laboratory ’s WADA accreditation be suspended or subjected to an Analytical Testing Restriction for a period of up to six (6) months (with one possible extension of up to six (6) months). |
During this time, any ISL and/or Technical Document and/or Technical Letter noncompliance(s) identified within the context of the Disciplinary Proceedings instituted against the Laboratory and resulting in the Suspension of its WADA accreditation or the imposition of an Analytical Testing Restriction , or during a subsequent assess ment conducted by WADA during the Laboratory ’s Suspension or during the period of the Analytical Testing Restriction , shall be corrected, documented, reported to WADA and determined to be satisfactory by WADA. |
The DC shall also indicate any conditions that the Laboratory shall satisfy prior to or after reinstatement of the Laboratory ’s WADA accreditation. |
In cases where it considers that it is appropriate to do so, the DC may also recommend to the Chair of the WADA Executive Committee that the Laboratory receive a private warning with out the imposition of a period of Suspension or Analytical Testing Restriction . |
The Laboratory may also be requested to take 33 The decision may be summarily reasoned. |
ISL – January 2021 Page 159 of 160 specified action(s) to resolve the issues identified within a defined timeline . |
The recommendation of the DC shall be provided to the Chair of the WADA Executive Committee without delay. |
If the DC recommends the Suspension of the Laboratory ’s WADA accreditation or the imposition of an Analytical Testing Restriction , the Chair of the WADA Executive Committee shall render a final decision regarding the Suspension of the Laboratory ’s WADA accreditation or the imposition of an Analytical Testing Restriction within ten (10) days of receiving the DC’s recommendat ion. |
If the DC recommends the Revocation of the Laboratory ’s WADA accreditation, the WADA Executive Committee shall render a decision regarding the Revocation of the Laboratory ’s WADA accreditation within fourteen (14) days of receiving the DC’s recommendation. |
If the DC recommends to the Chair of the WADA Executive Committee that the Laboratory shall maintain its WADA accreditation, and the Chair of the WADA Executive Committee accepts the DC’s recommendation, the Laboratory shall be informed acc ordingly by WADA within seven (7) days of receiving the Chair of the WADA Executive Committee’s decision . |
Part V – Expedited Proceedings or Single Hearing before CAS Article 8 Where required by the circumstances, the DC may, at the request of WADA or the Laboratory , conduct disciplinary proceedings in an expedited manner. |
In such situations, the DC may issue appropriate directions and modify the timelines indicated in these Proc edural Rules as required and justified by the circumstances, but must ensure that the principles of procedural fairness, and the requirements otherwise stated in these Procedural Rules, are respected at all times. |
The decision to conduct disciplinary proc eedings in an expedited manner shall be at the sole discretion of the DC and shall not be subject to appeal. |
If required due to time constraints, the DC may issue an operative recommendation to the Chairman of the WADA Executive Committee or the WADA Executive Committee, as applicable, with reasons to follow. |
In cases of a Suspension or an Analytical Testing Restriction , the Chairman of the WADA Executive Committee or, in cases of Revocation , the WADA Executive Committee, shall endeavor to render a decision regarding the status of the Laboratory ’s WADA accreditation as soon as reasonably possible. |
Once received, WADA shall provide the decision to the Laboratory without delay. |
[Comment: The Laboratory or WADA may request that disciplinary proceedings be conducted in an expedited manner if a decision regarding the status of the Laboratory ’s WADA accreditation must be made shortly prior to the commencement of a Major Event or Event or if otherwise justified by the circumstances.] |
Article 9 The Laboratory and WADA may agree to have the assertion of a noncompliance(s) with the ISL and/or Technical Document (s) and/or Technical Letters heard in a single hearing directly before a three (3)- ISL – January 2021 Page 160 of 160 member Panel of the CAS Anti-Doping Division in accordance with the Arbitration Rules for the CAS Anti-Doping Division. |
With the consent of WADA and the Laboratory , the proceedings may be conducted in an expedited manner in accordance with the Arbitration Rules for the CAS Anti-Doping Division. |
2023 ISTI – Effective 1 January 2023 Page 2 of 92 International Standard for Testing and Investigations The World Anti -Doping Code International Standard for Testing and Investigations is a mandatory International Standard developed as part of the World Anti -Doping Program. |
It was developed in consultation with Signatories , public authori ties, and other relevant stakeholders. |
The International Standard for Testing was first adopted in 2003 and came into effect in January 2004. |
It was subsequently amended six times, the first time effective January 2009 ; the second time effective January 2011 ; the third time it was renamed International Standard for Testing and Investigations (ISTI), effective January 2015; the fourth time effective January 2017 ; the fifth time effective March 2019 ; the sixth time effecti ve March 2020 and the seventh time effective January 2021 . |
This version of the ISTI incorporates further revisions approved by the WADA Executive Committee in September and November 2022 and is effective as of 1 January 2023 . |
Published by: World Anti -Doping Agency Stock Exchange Tower 800 Place Victoria (Suite 1700) PO Box 120 Montreal, Quebec Canada H4Z 1B7 www.wada -ama.org Tel: +1 514 904 9232 Fax: +1 514 904 8650 E-mail: code@wada- ama.org ISTI – Effective 1 January 2023 Page 3 of 92 TABLE OF CONTENTS PART ONE: INTRODUCTION, CODE PROVISIONS, INTERNATIONAL STANDARD PROVISIONS AND DEFINITIONS ............................................................................................................................... 6 1.0 Introduction and S cope ............................................................................................................................6 2.0 Code Provisions .......................................................................................................................................6 3.0 Definitions and Interpretation .................................................................................................................7 3.1 Defined Terms from the Code that are used in the International Standard for Testing and Investigations ....................................................................................................................................................................7 3.2 Defined Terms from the International Standard for Laboratories: ........................................................... 12 3.3 Defined T erms from the International Standard for Results Management : ............................................. 14 3.4 Defined Terms from the International Standard for the Protection of Privacy and Personal Information: ................................................................................................................................................................. 14 3.5 Defined Terms specific to the International Standard for Testing and Investigations: ............................ 14 3.6 Interpretation: .......................................................................................................................................... 16 PART TWO: STANDARDS FOR TESTING ........................................................................................ 18 4.0 Planning Effective Testing ................................................................................................................... 18 4.1 Objective .................................................................................................................................................. 18 4.2 Risk Assessment ..................................................................................................................................... 18 4.3 Defining International -Level and National -Level Athletes ....................................................................... 19 4.4 Prioritizing Between Sports and/or Disciplines ........................................................................................ 20 4.5 Prioritizing Between Different Athletes .................................................................................................... 21 4.6 Prioritizing Between Different Types of Testing and Samples ................................................................ 24 4.7 Sample Analysis, Retention Strategy and Further Analysis .................................................................... 25 4.8 Collecting Whereabouts Information ....................................................................................................... 25 4.9 Coordinating with Other Anti -Doping Organizations ............................................................................... 40 5.0 Notification of Athletes ......................................................................................................................... 41 5.1 Objective .................................................................................................................................................. 41 5.2 General .................................................................................................................................................... 41 5.3 Requirements Prior to Notification of Athletes ........................................................................................ 41 5.4 Requirements for Notification of Athletes ................................................................................................ 43 6.0 Preparing for the Sample Collection Session .................................................................................... 45 6.1 Objective .................................................................................................................................................. 45 6.2 General .................................................................................................................................................... 45 6.3 Requirements for Preparing for Sample Collection Session ................................................................... 46 7.0 Conducting the Sample Collection Session ....................................................................................... 49 7.1 Objective .................................................................................................................................................. 49 7.2 General .................................................................................................................................................... 49 7.3 Requirements Prior to Sample Collection ............................................................................................... 50 7.4 Requirements for Sample Collection ....................................................................................................... 50 8.0 Security/Post -Test Administration ...................................................................................................... 53 8.1 Objective .................................................................................................................................................. 53 8.2 General .................................................................................................................................................... 53 8.3 Requirements for Security/Post -Test Administration .............................................................................. 53 9.0 Transport of Samples and Documentation ......................................................................................... 54 9.1 Objective .................................................................................................................................................. 54 9.2 General .................................................................................................................................................... 54 9.3 Requirements for Transport and Storage of Samples and Documentation ............................................ 54 ISTI – Effective 1 January 2023 Page 4 of 92 10.0 Ownership of Samples .......................................................................................................................... 55 PART THREE: STANDARDS FOR INTELLIGENCE GATHERING AND INVESTIGATIONS ............. 56 11.0 Gathering, Assessment and Use of Intelligence ................................................................................ 56 11.1 Objective .................................................................................................................................................. 56 11.2 Gathering of Anti -Doping Intelligence ...................................................................................................... 56 11.3 Assessment and Analysis of Anti -Doping Intelligence ............................................................................ 56 11.4 Intelligence Outcomes ............................................................................................................................. 57 12.0 Investigations ........................................................................................................................................ 57 12.1 Objective .................................................................................................................................................. 57 12.2 Investigating Possible Anti -doping Rule Violations ................................................................................. 58 12.3 Investigation Outcomes ........................................................................................................................... 59 ANNEX A - MODIFICATIONS FOR ATHLETES WITH IMPAIRMENTS ............................................. 61 A.1. |
Objective ................................................................................................................................................... 61 A.2. |
Scope ........................................................................................................................................................ 61 A.3. |
Responsibility ........................................................................................................................................... 61 A.4. |
Requirements ........................................................................................................................................... 61 ANNEX B - MODIFICATIONS FOR ATHLETES WHO ARE MINORS ................................................ 63 B.1 Objective ................................................................................................................................................... 63 B.2 Scope ........................................................................................................................................................ 63 B.3 Responsibility ........................................................................................................................................... 63 B.4 Requirements ........................................................................................................................................... 63 ANNEX C - COLLECTION OF URINE SAMPLES .............................................................................. 65 C.1 Objective ................................................................................................................................................... 65 C.2 Scope ........................................................................................................................................................ 65 C.3 Responsibility ........................................................................................................................................... 65 C.4 Requirements ........................................................................................................................................... 65 ANNEX D - COLLECTION OF VENOUS BL OOD SAMPLES ............................................................. 68 D.1 Objective ................................................................................................................................................... 68 D.2 Scope ........................................................................................................................................................ 68 D.3 Responsibility ........................................................................................................................................... 68 D.4 Requirements ........................................................................................................................................... 68 ANNEX E - URINE SAMPLES - INSUFFICIENT VOLUME ................................................................. 71 E.1 Objective ................................................................................................................................................... 71 E.2 Scope ........................................................................................................................................................ 71 E.3 Responsibility ........................................................................................................................................... 71 E.4 Requirements ........................................................................................................................................... 71 ANNEX F - URINE SAMPLES THAT DO NOT MEET THE REQUIREMENT FOR SUITABLE SPECIFIC GRAVITY FOR ANALYSIS ................................................................................................ 73 F.1 Objective ................................................................................................................................................... 73 F.2 Scope ........................................................................................................................................................ 73 F.3 Responsibility ........................................................................................................................................... 73 F.4 Requirements ........................................................................................................................................... 73 ANNEX G - SAMPLE COLLECTION PERSONNEL REQUIREMENTS .............................................. 75 G.1 Objective ................................................................................................................................................... 75 G.2 Scope ........................................................................................................................................................ 75 ISTI – Effective 1 January 2023 Page 5 of 92 G.3 Responsibility ........................................................................................................................................... 75 G.4 Requirements - Qualifications and Training .............................................................................................. 75 G.5 Requirements - Accreditation, R e-Accreditation and Delegation ............................................................. 76 ANNEX H - EVENT TESTING ............................................................................................................. 78 H.1 Objective ................................................................................................................................................... 78 H.2 Scope ........................................................................................................................................................ 78 H.3 Responsibility ........................................................................................................................................... 78 H.4 Requirements ........................................................................................................................................... 78 ANNEX I - COLLECTION, STORAGE AND TRANSPORT OF BLOOD ATHLETE BIOLOGICAL PASSPORT SAMPLES ....................................................................................................................... 80 I.1 Objective ................................................................................................................................................... 80 I.2 Requirements ........................................................................................................................................... 80 I.3 The Samp le Collection Procedure ............................................................................................................ 82 I.4 Transportation Requirements ................................................................................................................... 82 ANNEX J - COLLECTION, STORAGE AND TRANSPORT OF DRIED BLOOD SPOT SAMPLES .. 84 J.1 Objective ................................................................................................................................................. 84 J.2 Scope ...................................................................................................................................................... 84 J.3 Responsibility ......................................................................................................................................... 84 J.4 Requirements for Dried Blood Spot Sample Collection Equipment ....................................................... 85 J.5 Dried Blood Spot Sample Provision ....................................................................................................... 85 J.6 Requirements for Transport.................................................................................................................... 88 ANNEX K - COLLECTION OF URINE SAMPLES IN A VIRTUAL ENVIRONMENT DURING A PANDEMIC ......................................................................................................................................... 89 K.1 Objective ................................................................................................................................................... 89 K.2 Scope ........................................................................................................................................................ 89 K.3 Res ponsibility ........................................................................................................................................... 89 K.4 Requirements for Dried Blood Spot Sample Collection Equipment ......................................................... 90 ISTI – Effective 1 January 2023 Page 6 of 92 PART ONE: INTRODUCTION, CODE PROVISIONS, INTERNATIONAL STANDARD PROVISIONS AND DEFINITIONS 1.0 Introduction and Scope The first purpose of the International Standard for Testing and Investigations is to plan for intelligent and effective Testing, both In-Competition and Out-of-Competition , and to maintain the integrity , identity and security of the Samples collected from the point the Athlete is notified of his/her selection for Testing, to the point the Samples are delivered to the Laboratory for analysis. |
To that end, the International Standard for Testing and Investigations (including its Annexes) establishes mandatory standards for Test distribution planning (including collection and use of Athlete whereabouts information), notification of Athletes , preparing for and conducting Sample collection, security/post -Test administration of Samples and documentation, and transport of Samples to Laboratories for analysis. |
The second purpose of the International Standard for Testing and Investigations is to establish mandatory standards for the efficient and effective gathering, assessment and use of anti -doping intelligence and for the efficient and effective conduct of investigations into possible anti -doping rule violations. |
The International Standard for Testing and Investigations is supported by Technical Documents , produced by WADA , to provide assist ance to Anti-Doping Organizations in fulfilling their duties under the World Anti -Doping Program. |
Technical Documents are mandatory. |
The Results Management processes which were previously contained in the International Standard for Testing and Investigations are now reflected in the Intern ational Standard for Results Management . |
Terms used in this International Standard that are defined terms from the Code are italicized. |
Terms that are defined in this or another International Standard are underlined. |
2.0 Code Provisions The following articles in the Code are directly relevant to the International Standard for Testing and Investigations; they can be obtained by referring to the Code itself: • Article 2 Anti-Doping Rule Violations • Article 5 Testing and Investigations • Article 6 Analysis of Samples • Article 8 Results Management : Right to a Fair Hearing and Notice of Hearing Decision • Article 10 Sanctions on Individuals • Article 12 Sanctions by Signatories Against Other Sporting Bodies • Article 13 Result s Management : Appeals • Article 14 Confidentiality and Reporting • Article 20 Additional Roles and Responsibilities of Signatories and WADA ISTI – Effective 1 January 2023 Page 7 of 92 • Article 21 Additional Roles and Responsibilities of Athletes and Other Persons • Article 23 Acceptance and Implementation 3.0 Definitions and Interpretation 3.1 Defined Terms from the Code that are used in the International Standard for Testing and Investigations ADAMS : The Anti -Doping Administration and Management System is a Web- based database management tool for data entry, storage, sharing, and reporting designed to assist stakeholders and WADA in their anti -doping operations in conjunction with data protection legislation. |
Adverse Analytical Finding: A report from a WADA -accredited laboratory or other WADA -approved laboratory that, consistent with the International Standard for Laboratories , establishes in a Sample the presence of a Prohibited Substance or its Metabolites or Markers or evidence of the Use of a Prohibited Method. |
Adverse Passport Finding: A report identified as an Adverse Passport Finding as described in the applicable International Standards . |
Anti-Doping Organization: WADA or a Signatory that is responsible for adopting rules for initiating, implementing or enforcing any part of the Doping Control process. |
This includes, for example, the International Olympic Committee, the International Paralympic Committee, other Major Event Organizations that conduct Testing at their Events , International Federations, and National Anti -Doping Organizations. |
Athlete : Any Person who competes in sport at the international level (as defined by each International Federation) or the national level (as defined by each National Anti -Doping Organization). |
An Anti-Doping Organization has discretion to apply anti -doping rules to an Athlete who is neither an International -Level Athlete nor a National -Level Athlete, and thus to bring them within the definition of “ Athlete”. |
In relation to Athletes who are neither International -Level nor National -Level Athletes, an Anti-Doping Organization ma y elect to: conduct limited Testing or no Testing at all; analyze Samples for less than the full menu of Prohibited Substances ; require limited or no whereabouts information; or not require advance TUEs . |
However, if an Article 2.1 , 2.3 or 2.5 anti-doping rule violation is committed by any Athlete over whom an Anti-Doping Organization has elected to exercise its authority to test and who competes below the international or national level, then the Consequences set forth in the Code must be applied. |
For purposes of Article 2.8 and Article 2.9 and for purposes of anti -doping information and Education, any Person who participates in sport under the authority of any Signatory , government, or other sports organization accepting the Code is an Athlete . |
[Comment to Athlete: Individuals who participate in sport may fall in one of five categories: 1) International -Level Athlete, 2) National -Level Athlete, 3) individuals who are not International or National -Level Athletes but over whom the International Federation or National Anti -Doping Organization has chosen to exercise authority, 4) Recreational Athlete, and 5) individuals over whom no International Federation or National Ant i-Doping Organization has, or has chosen to, exercise authority. |
All International and National -Level Athletes are subject to the anti -doping rules of the Code, with the precise definitions of international and national -level sport to be set forth in the anti-doping rules of the International Federations and National Anti -Doping Organizations .] |
ISTI – Effective 1 January 2023 Page 8 of 92 Athlete Biological Passport : The program and methods of gathering and collating data as described in the International Standard for Testing and Investigations and International Standard for Laboratories. |
Athlete Support Personnel : Any coach, trainer, manager, agent, team staff, official, medical, paramedical personnel, parent or any other Person working with, treating or assisting an Athlete participating in or preparing for sports Competition . |
Attempt: Purposely engaging in conduct that constitutes a substantial step in a course of conduct planned to culminate in the commission of an anti -doping rule violation. |
Provided, however, there shall be no anti -doping rule violation based solely on an Attempt to commit a violation if the Person renounces the Attempt prior to it being discovered by a third party not involved in the Attempt . |
Atypical Finding : A report from a WADA -accredited laboratory or other WADA -approved laboratory which requires further investigation as provided by the International Standard for Laboratories or related Technical Documents prior to the determination of an Adverse Analytical Finding. |
Atypical Passport Findi ng: A report described as an Atypical Passport Finding as described in the applicable International Standards . |
CAS : The Court of Arbitration for Sport . |
Code: The World Anti -Doping Code. |
Competition : A single race, match, game or singular sport contest. |
For example, a basketball game or the finals of the Olympic 100- meter race in athletics. |
For stage races and other sport contests where prizes are awarded on a daily or other interim basis , the distinction between a Competition and an Event will be as provided in the rules of the applicable International Federation. |
Consequences of Anti -Doping Rule Violations (“ Consequences”): An Athlete’s or other Person’s violation of an anti -doping rule may result in one or more of the following: (a) Disqu alification means the Athlete’s results in a particular Competition or Event are invalidated, with all resulting Consequences including forfeiture of any medals, points and prizes; (b) Ineligibility means the Athlete or other Person is barred on account of an anti -doping rule violation for a specified period of time from participating in any Competition or other activity or funding as provided in Article 10.14; (c) Provisional Suspension means the Athlete or other Person is barred te mporarily from participating in any Competition or activity prior to the final decision at a hearing conducted under Article 8 ; (d) Financial Consequences means a financial sanction imposed for an anti -doping rule violation or to recover costs associated w ith an anti -doping rule violation; and (e) Public Disclosure means the dissemination or distribution of information to the general public or Persons beyond those Persons entitled to earlier notification in accordance with Article 14 . |
Teams in Team Sports may also be subject to Consequences as provided in Article 11 . |
Decision Limit: The value of the result for a threshold substance in a Sample , above which an Adverse Analytical Finding shall be reported, as defined in the International Standard for Laboratories. |
ISTI – Effective 1 January 2023 Page 9 of 92 Delegated Third Part y: Any Person to which an Anti -Doping Organization delegates any aspect of Doping Control or anti -doping Education programs including, but not limited to, third parties or other Anti -Doping Organizations that conduct Sample collection or other Doping Control services or anti -doping Educational programs for the Anti -Doping Organization, or individuals serving as independent contractors who perform Doping Control services for the Anti-Doping Organization (e.g., non -employee Doping Control officers or chaperones).This definition does not include CAS . |
Doping Control : All steps and processes from test distribution planning through to ultimate disposition of any appeal and the enforcement of Consequences , including all steps and processes in between, including but not limited to, Testing, investigation, whereabouts, TUEs , Sample collection and handling, laboratory analysis, Results Management and investigations or proceedings relating to violations of Article 10.14 (Status During Ineligibility or Provisional Suspension). |
Education: The process of learning to instill values and develop behaviors that foster and protect the spirit of sport, and to prevent intentional and unintentional doping. |
Event : A series of individual Competitions conducted together under one ruling body (e.g., th e Olympic Games, World Championships of an International Federation, or Pan American Games). |
Event Venues: Those venues so designated by the ruling body for the Event . |
In-Competition : The period commencing at 11:59 p.m. on the day before a Competition in which the Athlete is scheduled to participate through the end of such Competition and the Sample collection process related to such Competition. |
Provided, however, WADA may approve, for a particular sport, an alternative definition if an International Federation provides a compelling justification that a different definition is necessary for its sport; upon such approval by WADA , the alternative definition shall be follow ed by all Major Event Organizations for that particular sport. |
[Comment to In- Competition: Having a universally accepted definition for In -Competition provides greater harmonization among Athletes across all sports, eliminates or reduces confusion among Athletes about the relevant timeframe for In -Competition Testing, avoids inadvertent Adverse Analytical Findings in between Competitions during an Event and assists in preventing any potential perfo rmance enhancement benefits from Substances prohibited Out-of-Competition being carried over to the Competition period.] |
Independent Observer Program : A team of observers and/or auditors, under the supervision of WADA , who observe and provide guidance on the Doping Control process prior to or during certain Events and report on their observations as part of WADA’s compliance monitoring program. |
Ineligibility : See Consequences of Anti -Doping Rule Violations above. |
Inter national Event : An Event or Competition where the International Olympic Committee, the International Paralympic Committee, an International Federation, a Major Event Organization, or another international sport organization is the ruling body for the Event or appoints the technical officials for the Event. |
ISTI – Effective 1 January 2023 Page 10 of 92 International -Level Athlete : Athletes who compete in sport at the international level, as defined by each International Federati on, consistent with the International Standard for Testing and Investigations. |
[Comment to International -Level Athlete: Consistent with the International Standard for Testing and Investigations, the International Federation is free to determine the criteria it will use to classify Athletes as International -Level Athletes, e.g., by ranking, by participation in particular International Events, by type of license, etc. |
However, it must publish those criteria in clear and concise form, so that Athletes a re able to ascertain quickly and easily when they will become classified as International -Level Athletes. |
For example, if the criteria include participation in certain International Events, then the International Federation must publish a list of those Int ernational Events.] |
International Standard: A standard adopted by WADA in support of the Code. |
Compliance with an International Standard (as opposed to another alternative standard, practice or procedure) shall be sufficient to conclude that the procedure s addressed by the International Standard were performed properly. |
International Standards shall include any Technical Documents issued pursuant to the International Standard . |
Major Event Organizations: The continental associations of National Olympic Committees and other international multisport organizations that function as the ruling body for any continental, regional or other International Event . |
Marker : A compound, group of compounds or biological variable(s) that indicates the Use of a Prohibited Substance or Prohibited Method. |
Minor : A natural Person who has not reached the age of eighteen years. |
National Anti -Doping Organization: The entity(ies) designated by each country as possessing the primary authority and responsibility to adopt and implement anti -doping rules, direct the collection of Samples , manage test results and conduct Results Management at the national level . |
If this designation has not been made by the competent public authority(ies), the entity shall be the country’s National Olympic Committee or its designee. |
National Event : A sport Event or Competition involving International - or National -Level Athletes that is not an International Event . |
National -Level Athlete: Athletes who compete in sport at the national level, as defined by each National Anti -Doping Organization, consistent with the International Standard for Testing and Investigations. |
National Olympic Committee: The organization recognized by the International Olympic Committee. |
The term National Olympic Committee shall also include the National Sport Confederation in those countries where the National Sport Confederation assumes typical National Olympic Committee responsibilities in the anti -doping area. |
Out-of-Competition: Any period which is not In -Competition. |
Person: A natural Person or an organization or other entity. |
Prohibited Method : Any method so described on the Prohibited List . |
ISTI – Effective 1 January 2023 Page 11 of 92 Prohibited Substance: Any substance, or class of substances, so described on the Prohibited List. |
Protected Person : An Athlete or other natural Person who at the time of the anti -doping rule violation: (i) has not reached the age of sixteen (16) years; (ii) has not reached the age of eighteen (18) years and is not included in any Registered Testing Pool and has never competed in any International Event in an open category; or (iii) for reasons other than age , has been determined to lack legal capacity under applicable national legislation. |
[Comment to Protected Persons: The Code treats Protected Persons differently than other Athletes or Persons in certain circumstances based on the understandi ng that, below a certain age or intellectual capacity, an Athlete or other Person may not possess the mental capacity to understand and appreciate the prohibitions against conduct contained in the Code. |
This would include, for example, a Paralympic Athlet e with a documented lack of legal capacity due to an intellectual impairment. |
The term “open category” is meant to exclude competition that is limited to junior or age group categories.] |
Provisional Suspension: See Consequences of Anti -Doping Rule Violati ons above. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.